Iovance Biotherapeutics, Inc.

Healthcare

NASDAQ:IOVA · NASDAQ Global Market

Market Cap $1.41B Beta 0.70 P/E (TTM) -4.6

$3.91 -0.89%

-$0.04 today

52W Low $1.66High $5.63

Vol 17.40M · Avg 14.09M

EPS (TTM) -$0.85Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+111.35%

Period High

$5.41

Period Low

$1.69

Latest

$3.91

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Erasca, Inc.

NASDAQ:ERAS

$4.32B

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.53B

ArriVent BioPharma, Inc. Common Stock

NASDAQ:AVBP

$1.47B

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.42B

MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

$1.37B

MeiraGTx Holdings plc

NASDAQ:MGTX

$1.02B

Replimune Group, Inc.

NASDAQ:REPL

$833.91M

Astria Therapeutics, Inc.

ATXS

$718.13M

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

$580.92M

CytomX Therapeutics, Inc.

NASDAQ:CTMX

$472.82M

What is the latest IOVA filing?

The latest filing shown is 8-K dated Jun 10, 2026.

How many recent filings does IOVA have?

Intrinsic Alpha currently shows 20 recent filings for IOVA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.